首页> 外文期刊>European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fuer Pharmazeutische Verfahrenstechnik e.V >Potential roles of antisense oligonucleotides in cancer therapy. The example of Bcl-2 antisense oligonucleotides.
【24h】

Potential roles of antisense oligonucleotides in cancer therapy. The example of Bcl-2 antisense oligonucleotides.

机译:反义寡核苷酸在癌症治疗中的潜在作用。 Bcl-2反义寡核苷酸的例子。

获取原文
获取原文并翻译 | 示例
           

摘要

Antisense oligonucleotides have been widely used to specifically and selectively downregulate gene expression at the messenger RNA level. Even though oligonucleotides are commonly used in laboratories and clinical trials, they can induce non-specific effects that can lead to misinterpretation of experimentally-derived results. This review summarizes precautions one should take when using oligonucleotides. In addition, the role of one oligonucleotide, G3139, which is targeted to the coding region of bcl-2 messenger RNA, in inhibiting tumor progression in vitro and in clinical trials, is described.
机译:反义寡核苷酸已被广泛用于在信使RNA水平上特异性和选择性地下调基因表达。即使寡核苷酸通常在实验室和临床试验中使用,它们仍会诱导非特异性作用,从而导致对实验得出的结果的误解。这篇综述总结了使用寡核苷酸时应采取的预防措施。此外,描述了一种靶向bcl-2信使RNA编码区的寡核苷酸G3139在体外和临床试验中抑制肿瘤进展的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号